In 2023, the National Center for Complementary and Integrative Health (NCCIH) and National Institute on Aging (NIA), with co-funding support from NIH’s Office of Behavior and Social Sciences Research (OBSSR) and National Endowment for the Arts (NEA), funded four music research networks to promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will effectively guide future clinical studies on MBIs in the context of these health conditions; adopt consistent terminology and taxonomy; support interdisciplinary collaborations; and initiate 1-year pilot projects to test novel mechanistic hypotheses.
The purpose of the current FOA is to support 1-year pilot studies to generate the necessary preliminary data to strengthen future NIH applications for later-stage studies on mechanisms through which music may have a positive impact on health in the context of pain or AD/ADRD. These pilot studies will also facilitate multidisciplinary collaborations among neuroscientists, music therapists, musicians, and biomedical, behavioral, or social scientists.
Music-based interventions have been investigated for efficacy in the amelioration of symptoms related to acute pain, chronic pain, and AD/ADRD. However, when and how music may influence pain and AD/ADRD are unclear, and little is known about the mechanisms underlying the effects of MBIs.
The scientific scope of the pilot projects is limited to the following high-priority research areas, as outlined in the parent RFA-AT-23-009 for the research networks:
Research Area One
Mechanisms and Biomarkers
1. Exploration of innovative mechanistic hypotheses of the neural systems involved in the therapeutic effect of music (e.g., sensory, motor, cognitive, emotional/affective, reward, interoceptive systems) in acute pain, chronic pain, or AD/ADRD
2. Examination of non-neural physiological systems and novel measures (e.g., impact on related non-neural organs, biochemical and molecular signals, epigenetic modifications) relevant to music or MBIs for acute pain, chronic pain, or AD/ADRD
3. Investigation of psychological, behavioral, and social factors related to the effects of music or MBIs on acute pain, chronic pain, or AD/ADRD (including, but not limited to, predictors, moderators, or mediators of MBI treatment effects)
4. Investigation of psychological, behavioral, and social factors related to the effects of music or MBIs on acute pain, chronic pain, or AD/ADRD (including, but not limited to, predictors, moderators, or mediators of MBI treatment effects)
Research Area Two
Technologies, Tools, & Models
1. Development and/or testing of innovative animal models to study mechanisms and biomarkers of music or MBIs in the context of acute pain, chronic pain, or AD/ADRD
2. Development and/or testing of novel technologies to measure how music or MBIs impact the brain or body, or to monitor health-related responses relevant to acute pain, chronic pain, or AD/ADRD.